Closing the Knowledge Gap: Hepatitis B Reactivation in Immunosuppression | Zendy

Yassir Daghistani | Zendy; Fergus To | Zendy; Eric M. Yoshida | Zendy; Patrick Doyle | Zendy; Hin Hin Ko | Zendy; Mel Krajden | Zendy; Jason Kur | Zendy; Alnoor Ramji | Zendy; Kam Shojania | Zendy; Edward Tam | Zendy; John Wade | Zendy; G. D. F. Reid | Zendy; Siegfried R. Erb | Zendy; Mollie N. Carruthers | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Closing the Knowledge Gap: Hepatitis B Reactivation in Immunosuppression

Author(s) -

Yassir Daghistani,

Fergus To,

Eric M. Yoshida,

Patrick Doyle,

Hin Hin Ko,

Mel Krajden,

Jason Kur,

Alnoor Ramji,

Kam Shojania,

Edward Tam,

John Wade,

G. D. F. Reid,

Siegfried R. Erb,

Mollie N. Carruthers

Publication year - 2019

Publication title -

canadian journal of general internal medicine

Language(s) - English

Resource type - Journals

eISSN - 2369-1778

pISSN - 1911-1606

DOI - 10.22374/cjgim.v14i2.293

Subject(s) - medicine , immunosuppression , rheumatology , hbsag , hepatitis b virus , hepatitis b , family medicine , intensive care medicine , immunology , virus

Background The usage of immunosuppressive medications (ISMs), and specifically disease-modifying antirheumatic drugs (DMARDs), in a wide range of internal medicine subspecialties, has increased the risk of hepatitis B virus reactivation (HBVr). We assessed the understanding of HBVr using a Canada-wide survey. C a n a d i a n J o u r n a l o f G e n e r a l I n t e r n a l M e d i c i n e 18 V o l u m e 1 4 , I s s u e 2 , 2 0 1 9 O r i g i n a l A r t i c l e

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research